Jonathan W Simons MD
Jonathan W Simons MD
Chief Science Officer Marcus Foundation
Verified email at
Cited by
Cited by
Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ...
Cancer research 59 (22), 5830-5835, 1999
Identification of a chromosome 18q gene that is altered in colorectal cancers
ER Fearon, KR Cho, JM Nigro, SE Kern, JW Simons, JM Ruppert, ...
Science 247 (4938), 49-56, 1990
Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells …
H Zhong, K Chiles, D Feldser, E Laughner, C Hanrahan, MM Georgescu, ...
Cancer research 60 (6), 1541-1545, 2000
In vivo molecular and cellular imaging with quantum dots
X Gao, L Yang, JA Petros, FF Marshall, JW Simons, S Nie
Current opinion in biotechnology 16 (1), 63-72, 2005
Nanotechnology applications in cancer
S Nie, Y Xing, GJ Kim, JW Simons
Annu. Rev. Biomed. Eng. 9, 257-288, 2007
The genomic complexity of primary human prostate cancer
MF Berger, MS Lawrence, F Demichelis, Y Drier, K Cibulskis, ...
Nature 470 (7333), 214-220, 2011
Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
ER Fearon, DM Pardoll, T Itaya, P Golumbek, HI Levitsky, JW Simons, ...
Cell 60 (3), 397-403, 1990
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group
GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...
Journal of Clinical Oncology 17 (11), 3461-3467, 1999
Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene
A Fazeli, SL Dickinson, ML Hermiston, RV Tighe, RG Steen, CG Small, ...
Nature 386 (6627), 796-804, 1997
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh, D Escuin, TM LaVallee, VS Pribluda, GM Swartz, ...
Cancer cell 3 (4), 363-375, 2003
Levels of hypoxia-inducible factor-1α during breast carcinogenesis
R Bos, H Zhong, CF Hanrahan, ECM Mommers, GL Semenza, HM Pinedo, ...
Journal of the national cancer institute 93 (4), 309-314, 2001
Expression of hypoxia‐inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression
D Zagzag, H Zhong, JM Scalzitti, E Laughner, JW Simons, GL Semenza
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells
R Rodriguez, ER Schuur, HY Lim, GA Henderson, JW Simons, ...
Cancer research 57 (13), 2559-2563, 1997
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
JB Nelson, SP Hedican, DJ George, AH Reddi, S Piantadosi, ...
Nature medicine 1 (9), 944-949, 1995
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry
Y Xing, Q Chaudry, C Shen, KY Kong, HE Zhau, LW Chung, JA Petros, ...
Nature protocols 2 (5), 1152-1165, 2007
Direct comparison of GAPDH, β-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia
H Zhong, JW Simons
Biochemical and biophysical research communications 259 (3), 523-526, 1999
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte …
JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ...
Cancer research 59 (20), 5160-5168, 1999
Tracking the clonal origin of lethal prostate cancer
MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ...
The Journal of clinical investigation 123 (11), 4918-4922, 2013
Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by ex Vivo Granulocyte-Macrophage Colony-stimulating Factor Gene Transfer
JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ...
Cancer research 57 (8), 1537-1546, 1997
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ...
Cancer research 61 (20), 7464-7472, 2001
The system can't perform the operation now. Try again later.
Articles 1–20